RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Moderate PE Treated with Thrombolysis (MOPETT Study)
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 4
SP 13
OP 14
DO 10.1177/155989771204007
UL http://mdc.sagepub.com/content/12/4/13.2.abstract
AB Pulmonary embolism (PE) is one of the most common preventable causes of death (responsible for >100,000 deaths annually) and the third leading cause of cardiovascular mortality. New data from the Moderate Pulmonary Embolism Treated with Thrombolysis [MOPETT] study suggest that moderate PE patients may be managed with reduced-dose issue plasminogen activator and modified anticoagulation.